Get startedLog in
    Picture of Lisata Therapeutics logo

    LSTA — Lisata Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Lisata Therapeutics - On Aug 3, Approved Reduction In Workforce By About 72% Effective Immediately - SEC Filing

    Picture of Lisata Therapeutics logoLisata Therapeutics
    04/08/2026 11:49
    BRIEF-Lisata Therapeutics - On Aug 3, Approved Reduction In Workforce By About 72% Effective Immediately - SEC Filing
    Aug 4 (Reuters) - Lisata Therapeutics Inc LSTA.O:
    • LISATA THERAPEUTICS - ON AUG 3, APPROVED REDUCTION IN WORKFORCE BY ABOUT 72% EFFECTIVE IMMEDIATELY - SEC FILING
    • LISATA THERAPEUTICS - ESTIMATES $1.20 MILLION OF COSTS RELATED TO WORKFORCE REDUCTION THROUGH QUARTER ENDING SEPT 30, 2026 - SEC FILING
    • LISATA THERAPEUTICS - TERMINATES KRISTEN K. BUCK AS EVP OF RESEARCH AND DEVELOPMENT AND CHIEF MEDICAL OFFICER EFFECTIVE AUG 3, 2026 - SEC FILING
    • LISATA THERAPEUTICS - ON JULY 31, COMMENCED LEGAL ACTION AGAINST KUVA LABS AND KUVA ACQUISITION CORP. FOR BREACH OF MERGER AGREEMENT - SEC FILING
    Source text: [ID:n0001140361-26-031028]
    Further company coverage: LSTA.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Lisata Therapeutics

    See all news